首页> 外文期刊>OncoTargets and therapy >miR-139-5p functions as a tumor suppressor in cervical cancer by targeting TCF4 and inhibiting Wnt/β-catenin signaling
【24h】

miR-139-5p functions as a tumor suppressor in cervical cancer by targeting TCF4 and inhibiting Wnt/β-catenin signaling

机译:miR-139-5p通过靶向TCF4并抑制Wnt /β-catenin信号传导在宫颈癌中发挥抑癌作用

获取原文
           

摘要

Objectives: Dysregulation of microRNAs (miRNAs) has been recognized as a crucial biological event in the development of cervical cancer (CC). miR-139-5p was identified as a significant tumor suppressor in multiple human cancers, leaving its roles and mechanisms in CC absolutely unclear. We aimed to investigate the implication of miR-139-5p in CC progression. Methods: miR-139-5p expression in 40 paired CC tissues and several cell lines was determined by qRT-PCR firstly. The implications of miR-139-5p in CC cell proliferation and migration were revealed by CCK-8, EdU and transwell assays, respectively. The mechanism underlying the tumor-suppressing roles of miR-139-5p in CC was investigated sequentially by dual luciferase, qRT-PCR, and Western blot analysis. The expression of transcription factor 4 (TCF4), the validated target of miR-139-5p from our experiments, was finally detected by qRT-PCR and immunohistochemistry in CC tissues, and its expression correlates with miR-139-5p was explored. Results: We found that miR-139-5p expression was frequently decreased in CC tissues and cell lines, and its lower level was associated with positive lymph node metastasis. Cellular assays proved the significant tumor-suppressing roles of miR-139-5p by inhibiting CC cell proliferation and migration, and markedly blocking Wnt/β-catenin signaling. Since bioinformatics analysis indicated TCF4 as a novel target of miR-139-5p, our mechanistic studies validated this, and confirmed that TCF4 restoration could attenuate the tumor inhibitory activities of miR-139-5p in CC progression, and recover the normal Wnt/β-catenin signaling. Conclusion: Our data collectively demonstrated that miR-139-5p was a vital tumor suppressor in CC pathogenesis via targeting TCF4 thereby inhibiting Wnt/β-catenin signaling. The miR-139-5p/TCF4 axis may serve as a promising target for CC therapy.
机译:目标:microRNA(miRNA)的失调已被认为是宫颈癌(CC)发展中的关键生物学事件。 miR-139-5p被确定为多种人类癌症中的一种重要的肿瘤抑制因子,因此其在CC中的作用和机制尚不清楚。我们旨在研究miR-139-5p在CC进展中的意义。方法:首先通过qRT-PCR检测miR-139-5p在40对配对的CC组织和几种细胞系中的表达。分别通过CCK-8,EdU和transwell分析揭示了miR-139-5p对CC细胞增殖和迁移的影响。通过双重荧光素酶,qRT-PCR和Western印迹分析依次研究了miR-139-5p在CC中抑制肿瘤的潜在机制。通过qRT-PCR和免疫组织化学检测CC实验中miR-139-5p的有效靶标转录因子4(TCF4)的表达,并探讨其与miR-139-5p的相关性。结果:我们发现miR-139-5p在CC组织和细胞系中的表达频繁降低,其较低水平与阳性淋巴结转移有关。细胞测定法通过抑制CC细胞增殖和迁移,并显着阻断Wnt /β-catenin信号传导,证明了miR-139-5p的显着肿瘤抑制作用。由于生物信息学分析表明TCF4是miR-139-5p的新靶标,因此我们的机理研究证实了这一点,并确认TCF4的修复可以减弱miR-139-5p在CC进展中的肿瘤抑制活性,并恢复正常的Wnt /β -连环蛋白信号传导。结论:我们的数据共同证明,miR-139-5p通过靶向TCF4从而抑制Wnt /β-catenin信号传导,在CC发病机制中是至关重要的肿瘤抑制因子。 miR-139-5p / TCF4轴可作为CC治疗的有希望的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号